Detection of Circulating mRNA Variants in Hepatocellular Carcinoma Patients Using Targeted RNAseq
Circulating RNA could be a robust analyte for noninvasive early detection of HCC and circulating RNA panels could be powerful tools in the entire spectrum of clinical management.
Authors
- Cataldo Doria (ORCID: https://orcid.org/0000-0001-8961-513X)
- Maarouf Hoteit (ORCID: https://orcid.org/0000-0001-6053-6884)
- Fowsiyo Ahmed (ORCID: https://orcid.org/0000-0002-0201-6706)
- Angela Simeone
- Lewis R. Roberts (ORCID: https://orcid.org/0000-0001-7885-8574)
- Timothy M. Block (ORCID: https://orcid.org/0000-0002-0343-7668)
- Tingting Zhan (ORCID: https://orcid.org/0000-0001-9971-4844)
- Daniel Zezulinski
- David E. Kaplan (ORCID: https://orcid.org/0000-0002-3839-336X)
- Aejaz Sayeed
Institutions
- Thomas Jefferson University (US)
- Mayo Clinic in Arizona (US)
- Qiagen (United Kingdom) (GB)
- Baruch S. Blumberg Institute (US)
- Capital Health (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1159/000545366
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Pennsylvania Department of Health
- University of South Carolina
- National Institutes of Health
- National Center for Advancing Translational Sciences